A review on the evolution of immunotherapy in bladder carcinoma
Bladder cancer is one of the most significant genitourinary cancer characterized by a high rate of recurrences, morbidity, and mortality in a large number of patients. Over the years, numerous therapeutic approaches have been developed. For more than 40 years, the most comprehensive method for the t...
Guardado en:
Autores principales: | Milena Gulinac, Dorian Dikov, Simeon Lichev, Tsvetelina Velikova |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Emergency Department of Hospital San Pedro (Logroño, Spain)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f01a364aa9a4f0583a3b4765ccdd9e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021) -
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Hongda Zhao, et al.
Publicado: (2021) -
An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
por: Seyed Saeed Tamehri Zadeh, et al.
Publicado: (2020) -
Lymphoepithelioma-Like Carcinoma of Urinary Bladder with Diagnostic Dilemma: Case Report of A Rare Variant of Urothelial Carcinoma
por: Swati Saini, et al.
Publicado: (2021) -
Infección diseminada por BCG en la Región de Los Lagos, Chile: Reporte de cinco casos clínicos
por: STRICKLER P,ALEXIS, et al.
Publicado: (2009)